PHGUF News and Press, Pharming Group Nv Ord From 03/17/22

Pharming Group N.V. press release (OTCPK:PHGUF): FY GAAP EPS of €0.02. Revenue of €198.9M (-6.3% Y/Y). For further details see: Pharming Group N.V. GAAP EPS of €0.02, revenue of €198.9M

Pharming Group N.V. (PHGUF) Q3 2021 Results Conference Call October 28, 2021 07:30 AM ET Company Participants Sijmen de Vries - CEO Dr. Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Co. Joe Pantginis - H.C. Wainright ...

Pharming Group N.V. (PHGUF) Q2 2021 Earnings Conference Call August 05, 2021 01:00 PM ET Company Participants Sijmen De Vries - Chief Executive Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Joe Pantginis - Wainwright Alex Cogut - Kempen Christian Glennie - St...

Orchard Therapeutics (ORTX) and Pharming Group (PHAR) announce a strategic collaboration to research, develop, manufacture and commercialize OTL-105, an investigational ex vivo autologous hematopoietic stem cell ((HSC)) gene therapy for the treatment of hereditary angioedema ((HAE)), a rare d...

Pharming Group made the first ever genetically modified animal in the world. Pharming Group's Ruconest has multiple complementary use-cases, apart from treating acute HAE attacks. Recent developments surrounding COVID-19 showcase that mutations continue to be a risk for reopening ...

Pharming Group's stock has had a lacklustre performance since it announced Ruconest might be effective at treating severe COVID-19 cases. Pharming Group's CEO announced that the company is planning to use genetically manipulated cows to expand production of Ruconest significantly. ...

LEIDEN, Netherlands , Aug. 17, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today announces the publication of data in the peer-reviewed journal, Frontiers in Immunology, from a compassionate use programme of five patients with co...

Delivered 14% increase in revenue, 31% increase in operating profit and 33% increase in net profit year-on-year LEIDEN, Netherlands , July 30, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) presents its (unaudited) financial report f...

LEIDEN, Netherlands , May 20, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces that at its Annual General Meeting of shareholders (AGM), held today, the proposals related to remuneration were withdrawn and all other proposal...

LEIDEN, Netherlands , May 16, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today supports "hae-day :-)", the global awareness day for hereditary angioedema (HAE), a rare life-threatening condition. On 16 May every year, the hae day ...